结果包合物的平均包合率为85。
RESULTS the average inclusion rate of the inclusion compound was 85.
对包合物的质量进行了考察。
微粉化物及包合物均有良好的稳定性。
Both micronized glibenclamide and inclusion complex were fairly stable.
用连续递变法测定了包合物的组成摩尔比。
The composition ratios of inclusion compounds were obtained by the continuous variation method.
比较了阿莫西林和包合物的体外溶出速率。
The dissolution rates of amoxicillin and inclusion complex were compared.
得到的笼形包合物中存在不同的弱相互作用。
There exist different weak interactions in the clathrate complexation.
采用差示扫描量热法(DSC)验证包合物。
The inclusion compound was identified by thermograms of differential scanning calorimetry (DSC).
目的：研究吡罗昔康包合物混悬液的鼻粘膜吸收。
Objective: To investigate the suspension of inclusion compound of piroxicam nasal absorption.
评价单纯包合物和包合物脂质体的体外释放行为；
The in vitro drug release profile of the HPCD complex and liposomes entrapping cinnarizine-HPCD complex were evaluated.
利用直流电弧法，合成了含钙的富勒烯金属包合物。
Ca-containing Endohedral Metallofullerenes were synthesized by DC arc discharge method.
但是它不是可口的零食。这里的包合物是指水包着甲烷。
But instead of a delicious snack-food the clathrate is water covered methane.
环糊精包合物的制备、结构、性质和应用研究日益广泛。
The studies on the preparation, structure, property and application of cyclodextrins have been in a wider and wider scope.
结论：采用密封控温技术制备中药包合物简便易行，迅速有效。
Conclusion: Preparation of inclusion complex was simple and quick by sealed-control temperature method.
目的建立适用于纳米铁包合物中铁及右旋糖酐含量测定的方法。
Objective to establish an optimal method to determine the contents of Fe and dextran in the nanometer iron compound.
包合物形成一种新的物相，且包合前后挥发油组成有一定的变化。
The change of the volatile oil component was found before and after inclusion.
产生了温室效应，反过来融化了海底甲烷包合物结构，将气体锁在冰中。
That produced a greenhouse effect which, in turn, melted seabed structures known as methane clathrates, which trap that gas in ice.
体外释放实验显示，包合物脂质体比单纯包合物有更好的血浆稳定性；
The in vitro release profile showed that the liposomes were more stable than cyclodextrin complex in human plasma.
一种异甜菊醇或其衍生物的超分子组合物及其制备，其形式是白色固体包合物。
The invention relates to a supramolecular composite of isosteviol or a derivative thereof and a preparation method thereof, and the form thereof is a white solid inclusion compound.
加热温度、加热时间对制备包合物的影响与替硝唑的稳定性在高温条件下被估测。
The influence of heating temperature, heating time on complex formation and the tinidazole stability under higher conditions of heating were evaluated.
挥发性试验结果，包合物的热失重比混合物小，说明包合物降低了大蒜油的挥发性。
In the volatility test, hot weightless of the complex was smaller than that of the mixture, indicating that inclusion complex was able to lower volatilization of garlic oil.
结果：在光照、高温条件下，包合物冻干粉中DATS含量下降程度为三者中最小。
RESULTS:The content of DATS in freeze-drying powders of inclusion complex had a minimum reduction among the three under conditions of illumination and high temperature.
本发明属于农药领域，特别是植物性杀虫剂的环糊精及其衍生物的包合物及其制备方法。
The present invention relates to farm chemical and especially plant pesticide clathrate and its preparation process.
本发明涉及药物领域，具体地，本发明涉及一种鼠类不育剂的环糊精包合物及其制备方法。
The invention relates to the field of medicaments, in particular to a cyclodextrin inclusion compound of a rodents sterilant and a preparation method thereof.
通过比较主-客体包合物生成常数的大小可以推断2与有机阴离子客体之间存在多重识别作用。
Comparison of the formation constants of inclusion compounds revealed that there is a multiple recognition mechanism in existence between the host molecule (2) and the organic anion guest.
通过选择条件制备啤酒花油-环糊精包合物，风味物质的含量在包合物稳定物质中可高达10%。
The content of flavoring substances in cyclodextrin complex was as high as 10 % through proper selection of hop oil-cyclodextrin complex preparation conditions.
在这种包合物中有机小分子是电子的受体，而碳笼则为电子的给体，这与金属富勒烯包合物恰恰相反。
The dopant is an electron acceptor and the cage is a donor which is different from the case of metallofullerenes.
结果所制备的包合物溶解度较槲皮素纯品增加约37倍，5分钟的溶出百分率较槲皮素纯品提高近10倍。
Results the aqueous solubility of quercetin was greatly increased (about 37 folds) by inclusion technique, and the initial dissolution rate was markedly improved (10 folds) in the first 5 min.
由于环糊精外部多羟基的亲水性，使形成的包合物具有良好的可润湿性，从而达到对难溶性药物的增溶效果。
For the exterior hydrophilic surface of CDs, inclusion complexes can have a good wettability, which will improve the water solubility of the poorly soluble drugs.
本发明公开了沙利度胺及其药学可接受的前药、盐、溶剂化物、水合物或包合物的药物组合物和单一单位剂型。
Pharmaceutical compositions and single unit dosage forms of thalidomide and pharmaceutically acceptable prodrugs, salts, solvates, hydrates, or clathrates are disclosed.
本发明公开了沙利度胺及其药学可接受的前药、盐、溶剂化物、水合物或包合物的药物组合物和单一单位剂型。
Pharmaceutical compositions and single unit dosage forms of thalidomide and pharmaceutically acceptable prodrugs, salts, solvates, hydrates, or clathrates are disclosed.
应用推荐